Bandingkan Harga & Kinerja Kokoh Inti Arebama Tbk (KOIN) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Kokoh Inti Arebama Tbk dan Organon Pharma Indonesia Tbk.: Kokoh Inti Arebama Tbk diperdagangkan di Rp78 (kapitalisasi pasar 78,47 M, volume 24 jam 61,5 rb), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Organon Pharma Indonesia Tbk. lebih besar dari sisi kapitalisasi pasar. Mana yang lebih baik tergantung tujuan investasimu.
| KOIN | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 78,47 M | 104,4 M |
Volume | 61,5 rb | — |
Lot | 615 | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Kokoh Inti Arebama Tbk
PT Kokoh Inti Arebama Tbk (the company) was established on 6 Jul 2001 based on Notaries Deed No. 27. The Company’s articles of association has been amended several times, most recently by notarial deed No. 7 of Mr. Nanda Fauz Iwan, SH., dated Aug 30, 2007, concerning among others, the change board commission and Company’s capital structure. PT Kokoh Inti Arebama is an Indonesia-based distributor. The Company is engaged in the distribution of ceramic wall, floor and roof tiles under the brands Lacassa, KIA and Impresso. The Company also acts as a distributor for sanitary products under the brand Claytan, paint products under the brand Kansai Paint and cement products under the brand Jaya Mortar. The Company has one subsidiary namely PT Karya Makmur Kreasi Prima. Headquartered in Jakarta, Indonesia, the Company has 16 branch offices and two stock points.
Selengkapnya di halaman KOIN →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
